{"disease":{"id":"depressive-disorder-treatment-resistant","name":"depressive disorder treatment resistant"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03109002","title":"An Epidemiology Study of Treatment Resistant Depression in the United States (US)","phase":"","overall_status":"COMPLETED","enrollment_count":200000,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT02691520","title":"Epidemiology of Treatment Resistant Depression in Taiwan","phase":"","overall_status":"COMPLETED","enrollment_count":8356,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT07189689","title":"Mental Health Mission Mood Disorder Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT03207282","title":"Treatment Resistant Depression in America Latina","phase":"","overall_status":"COMPLETED","enrollment_count":1539,"lead_sponsor_name":"Janssen-Cilag, S.A.","has_results":false},{"nct_id":"NCT02782104","title":"A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1148,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04039022","title":"Open-Label Safety Study of AXS-05 in Subjects With Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":876,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03373253","title":"Treatment-Resistant Depression Cohort in Europe","phase":"","overall_status":"COMPLETED","enrollment_count":830,"lead_sponsor_name":"Janssen-Cilag Ltd.","has_results":false},{"nct_id":"NCT02493868","title":"A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":719,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04599855","title":"A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":477,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT05973851","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":418,"lead_sponsor_name":"Dr. Inge Winter","has_results":false},{"nct_id":"NCT03434041","title":"A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT05570344","title":"rTMS With and Without Text4Support for the Treatment of Resistant Depression.","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT04428099","title":"Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression","phase":"NA","overall_status":"UNKNOWN","enrollment_count":186,"lead_sponsor_name":"University of the Balearic Islands","has_results":false},{"nct_id":"NCT05641623","title":"OSU6162 as add-on in SSRI/SNRI-resistant Depression","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Göteborg University","has_results":false},{"nct_id":"NCT05357040","title":"Antidepressant Effects of Nitrous Oxide","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":172,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT02422186","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT06396312","title":"Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Max-Planck-Institute of Psychiatry","has_results":false},{"nct_id":"NCT07262008","title":"Sustained Mood Improvement With Laughing Gas Exposure","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Women's College Hospital","has_results":false},{"nct_id":"NCT07210112","title":"Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":112,"lead_sponsor_name":"Centre Hospitalier St Anne","has_results":false},{"nct_id":"NCT06095778","title":"rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Changping Laboratory","has_results":false},{"nct_id":"NCT06480201","title":"Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":100,"lead_sponsor_name":"Texas A&M University","has_results":false},{"nct_id":"NCT04469959","title":"Dopaminergic Dysfunction in Late-Life Depression","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT06372834","title":"Adjuvant Accelerated piTBS for Reducing Suicidal Ideation in TRD Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Tri-Service General Hospital","has_results":false},{"nct_id":"NCT06341426","title":"Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05976009","title":"pBFS-Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Changping Laboratory","has_results":false},{"nct_id":"NCT04239651","title":"rTMS With and Without iCBT For the Treatment of Resistant Depression (TRD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT07528157","title":"Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT06938841","title":"Maintenance rTMS for Depression (Maitr-De)","phase":"NA","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT06255561","title":"pBFS Guided rTMS Over Different Targets for Treatment-Resistant Depression","phase":"NA","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Changping Laboratory","has_results":false},{"nct_id":"NCT05390593","title":"Treatment for Major Depressive Disorder With Intermittent Theta-burst Stimulation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03756129","title":"Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03288675","title":"Stepped Care AiTBS 2 Depression Study (Ghent)","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT03051256","title":"Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Relmada Therapeutics, Inc.","has_results":true},{"nct_id":"NCT07376018","title":"Ketogenic Diet and Neuromodulation in Treatment Resistant Depression","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT05680220","title":"40 Hz Light Neurostimulation for Patients With Depression (FELIX)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Klaus Martiny","has_results":false},{"nct_id":"NCT05870501","title":"Synaptic Imaging and Network Activity in Treatment Resistant Depression","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT06323486","title":"Accelerated Bilateral Sequential Theta Burst Stimulation in Older Adults With Treatment-resistant Depression","phase":"NA","overall_status":"UNKNOWN","enrollment_count":54,"lead_sponsor_name":"Ontario Shores Centre for Mental Health Sciences","has_results":false},{"nct_id":"NCT03851380","title":"Improving Brain Stimulation Through Imaging","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":54,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT07324070","title":"Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Charles University, Czech Republic","has_results":false},{"nct_id":"NCT06511908","title":"Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT05976022","title":"pBFS Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Changping Laboratory","has_results":false},{"nct_id":"NCT04841798","title":"MAO-B Occupancy in Depressed Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT05117710","title":"IMPase in Treatment-resistant Depression","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05887310","title":"In Vitro Modeling of Drug-resistant Psychiatric Disorders Using Induced Pluripotent Cells","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT02994433","title":"NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":49,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07053345","title":"A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":47,"lead_sponsor_name":"Janssen Korea, Ltd., Korea","has_results":false},{"nct_id":"NCT07474974","title":"ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":44,"lead_sponsor_name":"Polytechnic Institute of Porto","has_results":false},{"nct_id":"NCT03932825","title":"Nitrous Oxide for Major Depressive Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Lingjiang Li","has_results":false},{"nct_id":"NCT06230757","title":"Psilocybin for Treatment-Resistant Depression","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04701866","title":"Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Douglas Mental Health University Institute","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}